Prevention of the cytokine storm in COVID-19
Contenu
Click for External Resource*
Click to read full article*
*The link above may share a zip file (.zip) hosted on repository.netecweb.org. Zip files will download automatically.
*All other links are external and will open in a new window. If you click an external link, you are leaving the NETEC site, and we do not maintain, review, or endorse these materials. See our terms of use.
Item Type
PublicationTerms of Use
By accessing these materials you are agreeing to our terms of use, which may be found here: Terms of Use.
Titre
Prevention of the cytokine storm in COVID-19
Sujet
Description
The Comment by Marc Feldman and colleagues,1 published recently in The Lancet, discussed the potential of anti-tumor necrosis factor (TNF) therapy to inhibit development of a cytokine storm in patients with coronavirus disease 2019 (COVID-19). Following this Comment, I write to propose that the opioid, meptazinol, might be a possible alternative or addition to anti-TNF therapy, particularly in the UK, where meptazinol is a licensed drug (current licenced supplier Almirall, Barcelona, Spain) and thus could be easily prescribed.
Créateur
Date
2020-05-07
Type
Citer ce document
Wright, David J. M. 2020. "Prevention of the cytokine storm in COVID-19." The Lancet Infectious Diseases.
Accessibilité
Free online on Lancet site.
Was this resource helpful?